Background: Heavy-chain diseases (HCDs) are human lymphoproliferative neoplasias that are characterized by the secretion of truncated immunoglobulin heavy chains devoid of light chains. We have previously proposedby analogy to the process by which mutated growth factor receptors can be oncogenic -that because the genetic defects in HCDs result in the production of abnormal membrane-associated heavy chains lacking an antigen-binding domain, these abnormal B-cell antigen receptors might engage in ligand-independent signalling. Normal pre-B-cell development requires the presence of the pre-B-cell receptor, formed by the association of . heavy chains with two polypeptides -so-called surrogate light chains, Vpre B and X5 -that are homologous to the variable and constant portions of immunoglobulin light chains, respectively. To assess whether amino-terminal truncation of membrane-associated heavy chains results in their constitutive activation, we have examined the ability of a HCD-associated Ip protein to promote pre-B-cell development in transgenic mice.
Background
Heavy-chain diseases (HCDs) are a set of human lymphoproliferative disorders [1] that are characterized by the clonal expansion of cells secreting truncated immunoglobulin heavy chains without associated light chains (and thus without the antigen-binding domain); such HCD proteins are encoded by abnormal heavychain genes [2] . We have previously hypothesized that the clonal expansion and differentiation of neoplastic HCD cells to the plasma-cell stage are related to a ligandindependent activation of signalling by the membraneassociated form of the truncated heavy chain [3] , a situation that is analogous to the constitutive activation of truncated oncogenic growth factor receptors [4] . According to this model, the truncated antigen receptor has a constitutive activity which mimics antigen binding, favouring the proliferation of mature B-cells and their differentiation to the plasma-cell stage.
In order to study the activity of a membrane-associated HCD protein, we created several lines of transgenic mice expressing a truncated human p. heavy chain (AVVL). The transgene, which lacks the rearranged VDJ exon, encodes a molecule similar to that found in two patients with HCD [5] . As a consequence of the early expression of the membrane-bound AVIt protein, rearrangement to V and DJ immunoglobulin gene segments is inhibited, and the transgene-encoded truncated pI molecule is expressed without surrogate light chain on the surface of cells that reach the peripheral lymphoid system [5] . This was an intriguing finding, because normally pre-B-cell development requires the presence of the pre-B-cell receptor, which is formed by the association of I heavy chains with two invariant polypeptides, VpreB and X5, which are homologous to the variable and constant portions of immunoglobulin light chains, respectively [6] . This complex, which might also contain the Ig-ot and Ig-1 3 co-receptor molecules [7, 8] , is involved in the transition of precursor B220+ cells from the CD43 + to the CD43-stage ( Fig.1 ; [9] ). The AVp. molecule contains the heavy-chain constant domains necessary for its association with Ig-t and Ig-P [10, 11] , but AVp. does not bind to light chains. This suggests that the truncated p. protein is also unable to bind to V re B and X5, implying that pre-B-cell development in Vp. mice is dependent on a pre-B-cell receptor devoid of these molecules.
Correspondence to: Daniel Corcos. Fig. 1 . The role of I. heavy-chain-bearing receptors in normal B-cell development. Well characterized developmental steps involving the complete RI heavy chain (after productive VDJ recombination) are shown schematically (from [6, 17, 18, 26, 28, [38] [39] [40] ). Other possible roles of the complete Cp chain (which is shown in pink) are not excluded. Surrogate light chains X5 and VpreB are shown in yellow. It should be noted that surface expression of the normal pre-B-cell receptor is low [39] or undetectable [401.
In AVi-transgenic mice, there is a variable level of B-cell depletion in peripheral lymphoid organs [5] , but it is not clear at which developmental stage this depletion occurs. In this study, we wanted to determine whether the truncated immunoglobulin heavy chain is able to promote maturation and/or survival of pre-B cells and, if this was the case, whether association with surrogate light chains (X5/VpreB) is required. We show here that aminoterminal truncation of the Ip chain results in pre-B-cell development which is independent of X5. We further suggest a mechanism for constitutive activation of the truncated p, chain, involving both self-aggregation of truncated chains and their failure to associate with the BiP chaperone.
Results

Expression of the AV~I protein permits the generation of pre-B cells
Defining the developmental stages of B cells in AVttransgenic mice is complicated by the fact that the truncated heavy chain can be expressed at high levels on the cell surface in the absence of light-chain production [5] , presumably because the mutant chain does not bind stably to the heavy-chain-binding protein BiP [12] . As a consequence, late pre-B cells cannot be distinguished from immature B cells by cell-surface markers. In order to characterize the effect of the truncated heavy chain on pre-B-cell development, therefore, we introduced a transgene encoding either AVI or a complete I. chain into mice homozygous for the scid mutation [13] . In these mice, which are unable to make productive rearrangements of their immunoglobulin genes, lymphopoiesis aborts after the pro-B CD43 + cell stage (Fig. 2a ) [14] .
The ability of the AVI transgene to promote pre-B-cell development in mice was compared to that of a complete jp transgene, termed hSp6, which consisted of the human constant p, region and a rearranged mouse heavychain variable (VH) region corresponding to the Sp6 idiotype [15] . In the hSp6-39 mouse line, which we used, the transgene -the expression of which was detected using anti-human IgM antibodies -was expressed on the surface of most B cells ( Table 1) . Expression of the chimeric heavy chain resulted in allelic exclusion of endogenous heavy chains.
Transgenic mice expressing either AVpI or hSp6 were serially crossed with homozygous SCID mice for two or more generations. Homozygosity for the scid mutation was diagnosed on the basis of serum immunoglobulin levels, because AVp.-and h[LSp6-transgenic non-SCID mice have nearly normal levels of endogenous immunoglobulin by four weeks (produced by plasma cells that have escaped allelic exclusion). Mice lacking detectable levels of immunoglobulin were considered homozygous for the sid mutation. Introduction of the complete px transgene promoted development of CD43-pre-B cells in these mice (Fig. 2a) but did not promote B-cell development, as previously shown by Reichman-Fried et al. [16] . The AVpL transgene was as efficient as the complete transgene in generating B220 + CD43-cells (Fig. 2a ) in bone marrow, and, like the complete Ip gene, it did not lead to a substantial increase of lymphoid cell numbers in the spleen (data not shown). This latter result might be due to cell lethality caused by chromosomal breaks, formed as a result of faulty light-chain gene rearrangements in SCID mice [16] .
A high proportion of bone marrow cells from AVL SCID mice expressed high levels of cell-surface AVp, protein (Fig. 2b) . The absence of light-chain gene rearrangements in bone marrow and spleen DNA from both types of transgenic SCID animals was confirmed by polymerase chain reaction (PCR) analysis (Fig. 3) . By these two criteria -presence of the cells mainly in the bone marrow, and absence of light-chain gene rearrangementwe infer that B220 + CD43-cells from AVp. SCID mice are pre-B cells, although a number of them express the truncated immunoglobulin on their surface. Because the AVpI transgene has the same ability as the complete px transgene to promote the development of B220
+ CD43-cells, we conclude that the truncated molecule, like the normal one, can participate in the formation of a pre-B-cell receptor that is able to transduce signals to the inside of the cell.
The AV. protein supports the generation of CD43-pre-B cells in the absence of X5 protein
To examine the possibility that AVp, acts in the absence of X5, we backcrossed mice containing the AVp. and complete p. transgenes with X5T/X5T mice [17] . These mice, which are deficient in the X5 protein as a result of a targeted disruption of the X5 gene, exhibit a marked reduction in the number of CD43-pre-B cells and immature B cells [9, 18] , which together constitute the large majority of B220 + CD43-cells in normal bone marrow. We thus examined the effect of the two different p, transgenes, introduced by serial crossings into X5-deficient mice, on this bone marrow cell population.
The analyses shown in Figure 4 indicate that the complete I, transgene had no effect, whereas the AVI gene was able to support the generation of the B220 + CD43-population. As in mice that have the wild-type X5 gene, most CD43-cells were small and expressed cell-surface AVI, proteins but not the endogenous heavy chain (data not shown). The mice used for the analysis shown in Figure 4 were two to three months old. The same results were obtained using six-to eight-month-old transgenic X5-deficient mice. The absolute numbers of bone marrow B220
1 ow CD43-cells -pre-B cells and immature B cells, equivalent to fractions D + E as defined by Hardy et al. [19] -were less than 1 x 105 per femur in all of the X5-deficient mice and in all of the X5-deficient mice carrying the complete p, transgene that were analyzed, in agreement with a published report [9] . In the three X5-deficient mice carrying the AVp. transgene, these numbers ranged from 3.5 x 105 to 12 x 105 cells per femur, and a similar number of these cells were found in AVp z mice carrying the wild-type .5 gene. As in mice carrying the wild-type X5 gene, B cells expressing cell-surface AVI. protein, but not expressing endogenous p, chains, were found in the spleen (data not shown). We thus conclude that pre-B-cell development in AVIL-transgenic mice does not require X5.
Pre-B-cell development in various AVti-transgenic lines
It has recently been shown that, in a unique y2b transgenic mouse line, B-cell development is dependent on the transgene integration site [20] . We therefore wanted to determine whether the ability to promote pre-B-cell development was a feature unique to our AV[.-6 line. In all AVu. and AVI.m lines (the AVtm construct differs from AVp. in that it encodes only the membrane-bound form of the truncated human p. heavy chain), high-level expression of the truncated p. human molecule on the cell surface is always associated with allelic exclusion of endogenous IgM expression ( [5] and data not shown). In four AVt. lines and one AVI.m line, very few B cells expressed endogenous cell-surface IgM (Table 1) , indicating that pre-B-cell development is dependent on the transgenic molecule. We therefore studied B-lineage cells in mice from these lines.
X5-independent pre-B-cell development Corcos et al.
In all but one mouse, the numbers of B220 1°W CD43-cells were comparable to those in transgenic mice expressing the complete pi chain (Table 1) . Therefore, the AV[, protein is able to sustain pre-B-cell development irrespective of the transgene integration site. In addition, transgenic AVp. and AVpm lines differ from hiLSp6-transgenic mice or control mice in that they lack mature B cells (B220high cells in Table 1 and Fig. 5 ).
AVp. chains form patches on the cell surface
Because our results suggested that the AV[l molecule is able to mediate intracellular signal transduction in the absence of the putative ligand for the pre-B-cell receptor, we investigated the mechanism responsible for this constitutive activation. The most likely hypothesis was that this signalling might involve the spontaneous aggregation of truncated membrane-associated heavy chains on the cell surface. This hypothesis is strengthened by the fact that serum HCD proteins have a tendency to polymerize [1] . We therefore determined whether surface AVp. molecules have a tendency to aggregate spontaneously. Bone marrow and spleen cells from AVer-and hp.Sp6-transgenic mice were collected at 4 C in the presence of sodium azide, and incubated under identical conditions with a biotinylated antihuman IgM antibodies, followed by staining with streptavidin-conjugated phycoerythrin.
In cells from hlpSp6-transgenic mice, the staining of cellsurface immunoglobulin was in a punctate pattern (Figs 6e,g ), whereas cells from non-transgenic mice were not stained (Figs 6a,c) . By contrast, staining was reproducibly patchy in cells from either AVpL-transgenic mice, or AVpL-transgenic X5-deficient mice (data not Fig. 3 . PCR analysis of K gene rearrangements in (a) bone marrow and (b) spleen from BALB/c, hSp6, AV.l, SCID, hLSp6 SCID or AVi. SCID mice. (c) Serial four-fold dilution of spleen DNA from normal mice in tail DNA. Upper panels show the 0.5 kbp amplification products, corresponding to VKJK1 joints. In all assays, the non-allelic insulin (INS) genes were co-amplified (lower panels), giving rise to two bands at 0.23 kbp and 0.72 kbp, which corresponded to amplification products of insulin genes 1 and 2, respectively, and to an additional band which was intermediate in size. Total bone marrow and total spleen cells were used in these experiments. The non-SCID AVIL-transgenic mouse had a three-fold reduction in the percentage of spleen B220
+ cells compared to control mice. Quantification of rearrangements, performed using a Phosphorimager (Molecular Dynamics), indicated that there was no difference between the levels of K rearrangements per B220 + cell in non-SCID AV.-transgenic mice and control mice.
shown). A striking example is shown in Figure 6g , and a more representative example in Figure 6k . Fig. 4 . Flow cytometric analysis of bone marrow from (a) hplSp6-or (b) AVpL-transgenic mice heterozygous or homozygous for a targeted mutation at the x5 locus (5T). Bone marrow cells from two-to three-month-old animals were analyzed after two-color staining for CD43 and B220, which was performed as outlined in natve explanation is tnat tme patcny pattern is annooayinduced, but this should only occur to a very limited extent as our observations were carried out within 10 minutes after transfer to room temperature. We cannot, of course, rule out the possibility that AVV. chains are present in aggregates of a size too small to be identifiable by light microscopy, and that the addition of antibodies induces very rapid patching due to the high multivalency of the aggregated AVpI chains. We did observe antibody-induced patching after prolonged incubation of hp.Sp6 cells at room temperature, but its extent never reached that observed with AVii-transgenic cells. The difference in labelling patterns was consistent over a large number of cells, and was reproducible from experiment to experiment. We therefore conclude that IgM containing the hp.Sp6 chain behaves like normal mouse IgM, whereas AVI. chains spontaneously aggregate.
Discussion
Signalling by the pre-B-cell receptor is generally thought to involve an interaction between an unknown ligand and the variable region of the p. heavy chain or X 5 /VpreB [6] .
The ability of the AVp. molecule to support the generation of CD43-pre-B cells in the absence of X5 (or conventional light chains) can therefore be taken as strong evidence for ligand-independent (constitutive) signalling. Alternatively, the putative ligand could interact with the constant region of the pL heavy chain. This possibility seems very unlikely, because transgenic mice expressing 8, a and y2b chains are able to sustain normal B-cell development [20] [21] [22] [23] even though their constant regions differ notably from that of p.. It has also recently been suggested that 5 might not act as part of a receptor, but as an adhesion molecule [24] . This now appears unlikely, given the ability of the AVp. molecule to compensate for a lack of X5. Finally, another model suggests that the normal pre-B-cell complex displays constitutive activity [25] . If true, this model would also imply there is ligand-independent signalling by the truncated complex.
A major prediction of our initial hypothesis of HCD pathogenesis is that expression of the membrane-associated form of an HCD protein would confer constitutive activation on the B-cell receptor. In the neoplastic cells of HCD patients, signalling by the abnormal B-cell receptor would mimic antigen-induced signalling on mature B cells, favouring selective clonal expansion of cells with abnormal receptors in the absence of antigen. Tumorigenesis does not occur in AVpI-transgenic mice, and expression of the transgene prevents full B-cell development (D.C., unpublished observations, and Fig. 7 ). This may be explained by the fact that the transgene is expressed early in B-cell development, as evidenced by allelic exclusion of endogenous heavy-chain genes [5] . Stimulation of the antigen Y low cells (6 % of the gated cells) express the transgene on the cell surface. These cells may be pro-B cells or, alternatively, immature B cells that have downregulated B220, similar to those found in the spleen [5] . These cells are not scored as B220
+ in Table 1 .
receptor of immature B cells has been shown, in numerous cases, to induce tolerance and to inhibit the development of mature B cells [26] [27] [28] (see Fig. 1 ). The phenotype of the AVp.-transgenic cells found in the peripheral lymphoid system is consistent with persistent signalling at the immature B-cell stage (A. Grandien and D.C., unpublished observations). However, such evidence is indirect, and the best proof for constitutive activation rests on the effects of HCD proteins at the pre-B-cell stage.
The mechanism by which amino-terminal truncation of membrane-associated heavy chains leads to ligandindependent signalling is likely to involve spontaneous aggregation. Interestingly, isolated normal heavy chains also tend to aggregate, and they are only solubilized by light chains [29] . However, in normal cells, heavy chains -in the absence of light chains -interact with BiPs, which retain them in the lumen of the endoplasmic reticulum. Unlike normal p, chains, transgenic . chain disease proteins are exported to the cell surface in the absence of light chains, indicating that they do not stably interact with BiP (Fig. 2b) . Moreover, it has been shown by others that naturally occurring truncated AVp chains do not associate with BiP [12] . Therefore, we suggest that the lack of interaction between these proteins may play a role in the self aggregation of AVp,. BiP is a (Table 1 and data not shown). Green circles represent the heavy-chain binding protein BiP, which interacts with the normal chain.
member of the hsp70 family of proteins, among the functions of which is to assist protein folding and to prevent aggregation [30] . Thus, it is tempting to speculate that membrane-associated HCD proteins might not be subject to regulation by BiP.
Conclusions
Expression of the truncated p. heavy chain promotes pre-B-cell development in the absence of surrogate light chains. This result strongly suggests that amino-terminal truncation of Ix is responsible for constitutive activation of its signalling capacity. In theory, constant stimulation of a mature B cell through its antigen receptor could provide a selective advantage to the cell, by promoting proliferation or survival, which would favour the emergence of a neoplasia [3, 31] . This seems to imply that, in HCD, the genetic event leading to abnormal immunoglobulin production occurs after the negative-selection stage, in mature B cells (see Fig. 7 ). In support of this idea, it has been suggested that some HCD proteins might be generated during the course of the constant region switch [32, 33] . However, it is not clear whether the production of truncated membrane-associated heavy chains, although necessary, would be sufficient to produce the disease, as carcinogenesis usually requires several genetic events [34] . In addition, in the case of (x chain disease, environmental factors might be required in order to sustain the abnormal proliferation [1] . An interesting possibility for membrane-associated heavy chains is that the mechanism by which they are constitutively activated might be related to their lack of regulation by the BiP chaperone. Because BiP is ubiquitous and is able to bind to numerous polypeptides, we believe that similar mechanisms may be involved in the activation of aminoterminally truncated growth factor receptors.
Materials and methods
Construction of the hp.sp6 plasmid The 9 kbp Hpal fragment of the AV[L plasmid [5] , which encompasses all of the constant region exons, was inserted into the pSV36 plasmid, which had been digested with EcoRI and blunt-ended. The pSV36 plasmid (provided by A. Iglesias [21] ) was designed to allow the insertion of DNA at a unique EcoRI site downstream of the mouse VH Sp6 region. All manipulations were carried out using standard procedures [35] .
Transgenic mouse lines
Mice expressing the AVp. and AVlm transgenes have been described [5] ; hSp6-transgenic mice were obtained as previously reported [5] . The hSp6 plasmid was linearized with BamHI prior to injection. Mice expressing the hSp6 transgene were identified by dot-blot hybridization of tail DNA using the pSV2-gpt plasmid. Transgenic mouse lines were maintained through matings with BALB/c mice; k5-deficient mice [17] , obtained from W. Muller and K. Rajewsky, were genotyped after breeding by PCR analysis of tail DNA. These mice were kept in a conventional mouse breeding facility. C.B-17-SCID mice (provided by M. Lieberman) were maintained in pathogen-free conditions. Diagnosis of homozygosity for the scid mutation was performed using a competitive radioimmunoassay for serum K chains.
Flow cytometric analysis
Spleen and bone marrow cells were stained with conjugated antibodies and analyzed on a Coulter Elite Flow fluorocytometer (Coulter Electronics, Hialeah, Florida). The following antibodies were used: fluorescein-conjugated monoclonal antihuman p, (Nordic, Tilburg, The Netherlands) or biotinconjugated monoclonal anti-human p (Janssen Chimica, Geel, Belgium), fluorescein-or biotin-conjugated rat monoclonal anti-mouse B220 (CALTAG Labs, San Fransisco, California), fluoresceinated human-absorbed goat anti-mouse p (CALTAG Labs) and fluoresceinated monoclonal anti-mouse CD43 (PharMingen, San Diego, California). Biotinylated antibodies were detected by subsequent staining with phycoerythrin-conjugated streptavidin (CALTAG Labs). Dead cells were excluded by propidium iodide staining. Analyses were carried out on cells in the lymphocyte gate, defined by forward and side scatter.
PCR analysis
Amplifications were performed on a DNA Thermal Cycler (Perkin Elmer, Northwalk, Connecticut) using AmpliTaq DNA Polymerase (Perkin Elmer). For the quantification of K gene rearrangements, amplifications were performed as described [36] using 30 ng of DNA (5 000 unsorted cells). In all assays the nonallelic insulin (INS) genes were co-amplified [5] . INS PCR products were detected using the labeled oligonucleotide 5'-TGGGTGTGTAGAAGAAGCC-3'. One fifth of each sample was subjected to agarose gel electrophoresis and INS PCR products were visualized by ethidium bromide staining; the sample volumes loaded for Southern blot hybridization were then corrected to give similar amounts of INS PCR products. The assay allows detection of less than % normal B cells in a heterogeneous cell population. Mice deficient in 5 were genotyped by PCR analysis of tail DNA, using a primer located in the first exon of the 5 gene, 5' to the neo gene in the 5T mutant -5'-AGCTCAGAGTA-GGACAGACT-3' -and a primer in the first intron, 3' to the neo gene -5'-GGCCTTGCAATTGATCGAGG-3', based on the published sequence [37] . Amplification products of 0.37 kbp (wild-type allele) and 1.4 kbp (targeted) were visualized by ethidium bromide staining.
Fluorescence microscopy
Spleen and bone marrow cells were stained at 4 C in PBS containing 3 % BSA, 0.02 % sodium azide and biotin-conjugated monoclonal anti-human (mouse IgG1, MH15-1; Janssen Chimica), followed by staining with phycoerythrinconjugated streptavidin (CALTAG Labs), as in the FACS analysis. Cell pellets were resuspended in cold PBS. For observation, 5 1I cell suspension was placed between a glass slide and a coverslip. Micrographs were obtained using a Nikon Microphot-FXA, with an XF39 filter (excitation filter 550 + 30 nm, dichroic mirror 575 nm, emission filter 615 ± 45 nm).
